Projected Stock Price
No data available.
Projected Revenue
No data available.
Projected Earnings Per Share
Estimated quarterly earnings by December 31, 2026.
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Gilead Sciences, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
In addition to being able to interpret financial data, stock analysts have connections within the companies they cover that give them access to information retail investors do not have.
Therefore, analyst ratings can help you find opportunities in the market. However, they are guidelines more than recommendations. This is why it’s important to look at analyst ratings over a period of time.
If analysts change their ratings frequently, you should pay close attention to the company’s fundamentals. For example, has there been a significant change to the company’s earnings growth and/or debt?
You should also pay attention to the number of analysts covering a stock over the course of a year. In general, the more analysts who cover the stock give the consensus rating more credibility, but each individual rating less overall weight.
Analyst ratings are one data point for you to consider. Here are some strategies you can use to fine tune your research.
Look at more than one analyst and don’t hesitate to look at analysts that have differing views. This can help challenge any preconceived ideas you have about a stock and point out ways in which your thesis for owning or avoiding a stock may have changed.
Compare a stock’s rating with other stocks in its industry or sector. In some cases, a stock is simply superior to others in its sector. However, at other times, it could be overvalued based on investor sentiment instead of fundamentals.
How are the Fintel Analyst Ratings different?Analyst ratings by Fintel are presented in close to real-time to stay ahead of generalized information flow. Combined with target price estimates and revenue estimates for the company you have greater accuracy despite market volatility.
Date | Analyst | Prior | Latest Recommendation |
Action |
---|---|---|---|---|
2025-02-12 | Wells Fargo | Overweight | Overweight | Maintains |
2025-02-12 | BMO Capital | Outperform | Outperform | Maintains |
2025-02-12 | Goldman Sachs | Neutral | Neutral | Maintains |
2025-02-12 | RBC Capital | Sector Perform | Sector Perform | Maintains |
2024-09-09 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
2024-11-21 | Mizuho | Outperform | Outperform | Maintains |
2025-03-04 | Oppenheimer | Outperform | Outperform | Maintains |
2024-11-21 | UBS | Neutral | Neutral | Maintains |
2024-08-15 | Truist Securities | Hold | Hold | Maintains |
2024-08-15 | Needham | Hold | Reiterate | |
2024-11-07 | Piper Sandler | Overweight | Overweight | Maintains |
2024-11-07 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2024-11-07 | Wells Fargo | Overweight | Overweight | Maintains |
2024-11-07 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
2024-11-07 | Goldman Sachs | Neutral | Neutral | Maintains |
2024-11-07 | RBC Capital | Sector Perform | Sector Perform | Maintains |
2024-11-07 | JP Morgan | Overweight | Overweight | Maintains |
2024-11-07 | Baird | Neutral | Neutral | Maintains |
2024-11-07 | BMO Capital | Outperform | Outperform | Maintains |
2024-11-07 | Oppenheimer | Outperform | Outperform | Maintains |
2024-11-07 | Needham | Hold | Reiterate | |
2025-01-10 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
2024-10-21 | Leerink Partners | Market Perform | Outperform | Upgrade |
2024-09-16 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
2024-10-07 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2024-10-07 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
2024-10-17 | BMO Capital | Outperform | Outperform | Maintains |
2024-10-17 | Bernstein | Outperform | Initiate | |
2024-11-14 | Citigroup | Buy | Initiate | |
2025-02-03 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
2024-11-15 | Wolfe Research | Outperform | Initiate | |
2024-11-08 | Truist Securities | Hold | Hold | Maintains |
2024-11-08 | Maxim Group | Buy | Hold | Downgrade |
2024-10-29 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
2024-08-09 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
2024-08-09 | RBC Capital | Sector Perform | Sector Perform | Maintains |
2024-08-09 | BMO Capital | Outperform | Outperform | Maintains |
2023-01-03 | RBC Capital | Outperform | Sector Perform | Downgrade |
2022-12-13 | B of A Securities | Neutral | Reiterate | |
2022-12-01 | Morgan Stanley | Equal-Weight | Maintains | |
2022-11-08 | Cowen & Co. | Outperform | Maintains | |
2022-11-08 | Mizuho | Buy | Maintains | |
2022-11-01 | SVB Leerink | Market Perform | Maintains | |
2022-10-31 | Maxim Group | Buy | Maintains | |
2022-10-31 | Barclays | Underweight | Equal-Weight | Upgrade |
2022-10-28 | Morgan Stanley | Equal-Weight | Maintains | |
2022-10-28 | RBC Capital | Outperform | Maintains | |
2022-10-28 | Wells Fargo | Equal-Weight | Maintains | |
2022-10-28 | Piper Sandler | Neutral | Overweight | Upgrade |
2022-10-28 | Truist Securities | Hold | Buy | Upgrade |
2022-10-13 | Morgan Stanley | Equal-Weight | Maintains | |
2022-10-12 | Barclays | Underweight | Maintains | |
2022-10-04 | JP Morgan | Neutral | Overweight | Upgrade |
2022-09-15 | Truist Securities | Hold | Maintains | |
2022-09-13 | Wells Fargo | Equal-Weight | Maintains | |
2022-07-26 | Piper Sandler | Neutral | Maintains | |
2022-07-15 | Morgan Stanley | Equal-Weight | Maintains | |
2022-07-13 | Cantor Fitzgerald | Neutral | Initiate | |
2022-05-23 | SVB Leerink | Market Perform | Initiate | |
2022-05-17 | Piper Sandler | Neutral | Maintains | |
2022-04-29 | BMO Capital | Market Perform | Maintains | |
2022-04-29 | Piper Sandler | Neutral | Maintains | |
2022-04-12 | Morgan Stanley | Equal-Weight | Maintains | |
2022-04-12 | RBC Capital | Outperform | Maintains | |
2022-04-04 | Piper Sandler | Neutral | Maintains | |
2022-03-22 | Wells Fargo | Equal-Weight | Maintains | |
2022-03-10 | Barclays | Underweight | Maintains | |
2022-03-08 | RBC Capital | Outperform | Maintains | |
2022-02-28 | BMO Capital | Outperform | Market Perform | Downgrade |
2022-02-08 | Mizuho | Buy | Maintains | |
2022-02-02 | Morgan Stanley | Equal-Weight | Maintains | |
2022-01-28 | Argus Research | Hold | Buy | Upgrade |
2022-01-18 | Morgan Stanley | Equal-Weight | Maintains | |
2022-01-06 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
2021-12-09 | Wells Fargo | Equal-Weight | Initiate | |
2021-12-06 | Goldman Sachs | Neutral | Initiate | |
2021-10-29 | SVB Leerink | Outperform | Maintains | |
2021-10-12 | Morgan Stanley | Overweight | Maintains | |
2021-07-30 | RBC Capital | Outperform | Maintains | |
2021-07-30 | SVB Leerink | Outperform | Maintains | |
2021-04-30 | SVB Leerink | Outperform | Maintains | |
2021-04-30 | Morgan Stanley | Overweight | Maintains | |
2021-04-19 | Morgan Stanley | Overweight | Maintains | |
2021-04-01 | Bernstein | Market Perform | Outperform | Upgrade |
2021-03-30 | Redburn | Neutral | Buy | Upgrade |
2021-02-11 | SVB Leerink | Outperform | Maintains | |
2021-02-05 | Credit Suisse | Neutral | Maintains | |
2021-02-05 | SVB Leerink | Outperform | Maintains | |
2021-02-05 | Morgan Stanley | Overweight | Maintains | |
2021-01-19 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
2024-07-22 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
2024-07-08 | Raymond James | Market Perform | Outperform | Upgrade |
2024-04-26 | RBC Capital | Sector Perform | Sector Perform | Maintains |
2024-04-26 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2024-04-26 | TD Cowen | Buy | Buy | Maintains |
2024-04-26 | Needham | Hold | Reiterate | |
2024-04-24 | HSBC | Reduce | Hold | Upgrade |
2024-04-19 | Oppenheimer | Outperform | Outperform | Maintains |
2024-04-17 | UBS | Neutral | Neutral | Maintains |
2024-03-04 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
2024-02-22 | Mizuho | Buy | Buy | Maintains |
2024-02-22 | Truist Securities | Buy | Hold | Downgrade |
2024-02-14 | RBC Capital | Sector Perform | Sector Perform | Maintains |
2024-02-12 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2024-02-12 | Oppenheimer | Outperform | Outperform | Maintains |
2024-02-07 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
2024-02-07 | RBC Capital | Sector Perform | Sector Perform | Maintains |
2024-02-07 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
2024-01-23 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2023-11-14 | RBC Capital | Sector Perform | Sector Perform | Maintains |
2023-11-09 | Deutsche Bank | Hold | Initiate | |
2023-09-08 | B of A Securities | Neutral | Buy | Upgrade |
2023-09-06 | Truist Securities | Buy | Buy | Reiterate |
2023-09-06 | HSBC | Reduce | Initiate | |
2023-08-04 | RBC Capital | Sector Perform | Sector Perform | Maintains |
2023-08-04 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2023-07-24 | Piper Sandler | Overweight | Overweight | Maintains |
2023-07-24 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
2023-07-24 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2023-07-20 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
2023-07-11 | Morgan Stanley | Equal-Weight | Equal-Weight | Reiterate |
2023-07-11 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2023-06-23 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
2023-05-16 | BMO Capital | Market Perform | Outperform | Upgrade |
2023-05-01 | Morgan Stanley | Equal-Weight | Maintains | |
2023-04-28 | RBC Capital | Sector Perform | Maintains | |
2023-04-25 | RBC Capital | Sector Perform | Reiterate | |
2023-04-12 | Morgan Stanley | Equal-Weight | Maintains | |
2023-03-06 | RBC Capital | Sector Perform | Maintains | |
2023-02-14 | Mizuho | Buy | Maintains | |
2023-02-03 | SVB Leerink | Market Perform | Maintains | |
2023-02-03 | Morgan Stanley | Equal-Weight | Maintains | |
2023-02-03 | Piper Sandler | Overweight | Maintains | |
2023-01-24 | Morgan Stanley | Equal-Weight | Maintains | |
2023-01-19 | Piper Sandler | Overweight | Maintains | |
2023-01-18 | Barclays | Equal-Weight | Maintains | |
2023-01-03 | Wells Fargo | Equal-Weight | Maintains | |
2016-04-29 | Maxim Group | Buy | Hold | Downgrade |
2016-04-29 | Citigroup | Buy | Maintains | |
2016-04-26 | Credit Suisse | Outperform | Maintains | |
2024-07-01 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
2024-06-20 | Baird | Neutral | Neutral | Maintains |
2024-06-14 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
2024-04-29 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2020-12-16 | Credit Suisse | Neutral | Maintains | |
2020-11-24 | Truist Securities | Buy | Initiate | |
2020-11-06 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
2020-11-03 | Morgan Stanley | Equal-Weight | Reiterate | |
2020-10-29 | BMO Capital | Market Perform | Maintains | |
2020-10-29 | Cantor Fitzgerald | Overweight | Reiterate | |
2020-10-29 | Piper Sandler | Overweight | Maintains | |
2020-10-29 | Wells Fargo | Equal-Weight | Maintains | |
2020-10-29 | SVB Leerink | Outperform | Maintains | |
2020-10-28 | UBS | Neutral | Initiate | |
2020-09-18 | RBC Capital | Outperform | Maintains | |
2020-09-15 | Maxim Group | Hold | Buy | Upgrade |
2020-09-15 | RBC Capital | Outperform | Maintains | |
2020-09-14 | SVB Leerink | Outperform | Maintains | |
2020-09-10 | Oppenheimer | Outperform | Maintains | |
2020-08-20 | Truist Securities | Hold | Maintains | |
2020-08-19 | Piper Sandler | Overweight | Maintains | |
2020-08-19 | Cantor Fitzgerald | Overweight | Maintains | |
2020-07-31 | Morgan Stanley | Equal-Weight | Maintains | |
2020-07-31 | Credit Suisse | Neutral | Maintains | |
2020-07-20 | Credit Suisse | Underperform | Neutral | Upgrade |
2020-07-15 | Morgan Stanley | Equal-Weight | Maintains | |
2020-05-26 | SunTrust Robinson Humphrey | Sell | Hold | Upgrade |
2020-05-21 | Cowen & Co. | Outperform | Initiate | |
2020-05-01 | Morgan Stanley | Equal-Weight | Maintains | |
2020-05-01 | Oppenheimer | Outperform | Maintains | |
2020-05-01 | SVB Leerink | Market Perform | Maintains | |
2020-05-01 | Raymond James | Outperform | Market Perform | Downgrade |
2020-05-01 | SunTrust Robinson Humphrey | Hold | Sell | Downgrade |
2020-05-01 | JP Morgan | Overweight | Neutral | Downgrade |
2020-04-29 | CFRA | Sell | Maintains | |
2020-04-27 | UBS | Buy | Neutral | Downgrade |
2020-04-20 | BMO Capital | Outperform | Market Perform | Downgrade |
2020-04-20 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
2020-04-17 | Baird | Neutral | Outperform | Upgrade |
2020-04-17 | CFRA | Hold | Sell | Downgrade |
2020-04-07 | Cantor Fitzgerald | Overweight | Reiterate | |
2020-03-20 | Piper Sandler | Neutral | Overweight | Upgrade |
2020-03-19 | Wells Fargo | Overweight | Maintains | |
2020-03-18 | DZ Bank | Hold | Buy | Upgrade |
2020-03-09 | RBC Capital | Top Pick | Outperform | Downgrade |
2020-02-28 | DZ Bank | Buy | Hold | Downgrade |
2020-02-27 | Barclays | Underweight | Initiate | |
2020-02-06 | Bernstein | Outperform | Market Perform | Downgrade |
2020-02-05 | Credit Suisse | Underperform | Maintains | |
2020-02-05 | Raymond James | Strong Buy | Outperform | Downgrade |
2020-02-05 | B of A Securities | Neutral | Maintains | |
2020-01-21 | Guggenheim Securities | Buy | Neutral | Downgrade |
2019-12-20 | Wells Fargo | Overweight | Maintains | |
2019-12-13 | Credit Suisse | Neutral | Underperform | Downgrade |
2019-11-12 | SunTrust Robinson Humphrey | Hold | Initiate | |
2019-11-05 | Wells Fargo | Outperform | Maintains | |
2019-10-25 | Oppenheimer | Outperform | Maintains | |
2019-10-25 | Maxim Group | Buy | Hold | Downgrade |
2019-10-25 | BMO Capital | Outperform | Maintains | |
2019-10-25 | Raymond James | Strong Buy | Maintains | |
2019-08-19 | Wells Fargo | Outperform | Initiate | |
2019-07-31 | Credit Suisse | Neutral | Maintains | |
2019-07-31 | Raymond James | Strong Buy | Maintains | |
2019-07-29 | RBC Capital | Outperform | Top Pick | Upgrade |
2019-07-15 | Wells Fargo | Market Perform | Outperform | Upgrade |
2019-05-28 | Goldman Sachs | Neutral | Sell | Downgrade |
2019-05-23 | Citigroup | Neutral | Buy | Upgrade |
2019-05-21 | Credit Suisse | Neutral | Initiate | |
2019-04-26 | Bernstein | Outperform | Initiate | |
2019-04-17 | Longbow Research | Buy | Neutral | Downgrade |
2019-04-10 | UBS | Neutral | Buy | Upgrade |
2019-03-15 | BMO Capital | Outperform | Initiate | |
2019-02-12 | Raymond James | Strong Buy | Strong Buy | Maintains |
2019-02-12 | Citigroup | Buy | Neutral | Downgrade |
2019-02-12 | Wells Fargo | Outperform | Market Perform | Downgrade |
2019-01-03 | Oppenheimer | Perform | Outperform | Upgrade |
2018-12-19 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2018-10-26 | Raymond James | Strong Buy | Strong Buy | Maintains |
2018-10-26 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
2018-10-26 | PiperJaffray | Overweight | Neutral | Downgrade |
2018-10-01 | Cantor Fitzgerald | Overweight | Initiate | |
2018-07-26 | Baird | Outperform | Neutral | Downgrade |
2018-07-26 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2018-06-28 | Raymond James | Strong Buy | Initiate | |
2018-06-19 | Baird | Outperform | Outperform | Maintains |
2018-05-02 | Barclays | Overweight | Overweight | Maintains |
2018-05-02 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2018-04-19 | Longbow Research | Neutral | Buy | Upgrade |
2018-03-06 | Barclays | Overweight | Overweight | Maintains |
2018-02-08 | BMO Capital | Outperform | Market Perform | Maintains |
2018-02-08 | Benchmark | Hold | Buy | Upgrade |
2018-02-07 | Leerink Swann | Market Perform | Market Perform | Maintains |
2018-02-07 | Bank of America | Neutral | Neutral | Maintains |
2018-02-07 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2018-01-30 | Citigroup | Neutral | Buy | Upgrade |
2018-01-26 | Jefferies | Hold | Buy | Upgrade |
2018-01-16 | Wells Fargo | Market Perform | Outperform | Upgrade |
2017-12-20 | Credit Suisse | Outperform | Neutral | Downgrade |
2017-11-30 | Maxim Group | Hold | Buy | Upgrade |
2017-11-13 | Argus | Buy | Hold | Downgrade |
2017-10-30 | Benchmark | Buy | Hold | Downgrade |
2017-10-27 | BMO Capital | Outperform | Maintains | |
2017-10-19 | Leerink Swann | Market Perform | Maintains | |
2017-10-06 | Morgan Stanley | Equal-Weight | Maintains | |
2017-10-05 | Oppenheimer | Perform | Initiate | |
2017-10-05 | Leerink Swann | Market Perform | Maintains | |
2017-10-04 | Bank of America | Neutral | Maintains | |
2017-09-15 | RBC Capital | Outperform | Initiate | |
2017-08-31 | Argus | Hold | Buy | Upgrade |
2017-08-29 | Credit Suisse | Outperform | Maintains | |
2017-07-26 | Redburn | Buy | Initiate | |
2017-06-23 | Deutsche Bank | Buy | Initiate | |
2017-03-09 | UBS | Buy | Neutral | Downgrade |
2017-02-08 | Citigroup | Buy | Neutral | Downgrade |
2016-12-01 | Summit Redstone Partners | Hold | Initiate | |
2016-11-14 | Stifel Nicolaus | Buy | Initiate | |
2016-11-08 | Mizuho | Buy | Initiate | |
2016-11-02 | BMO Capital | Market Perform | Outperform | Upgrade |
2016-10-05 | Jefferies | Buy | Maintains | |
2016-10-03 | RBC Capital | Outperform | Maintains | |
2016-09-27 | Leerink Swann | Outperform | Market Perform | Downgrade |
2016-09-22 | Berenberg | Buy | Initiate | |
2016-09-14 | Credit Suisse | Outperform | Maintains | |
2016-09-12 | Berenberg | Buy | Initiate | |
2016-09-06 | Jefferies | Hold | Buy | Upgrade |
2016-08-31 | Jefferies | Hold | Maintains | |
2016-07-29 | Argus | Buy | Hold | Downgrade |
2016-07-26 | Needham | Buy | Hold | Downgrade |
2016-06-01 | Gabelli & Co. | Buy | Initiate | |
2016-05-26 | Morgan Stanley | Equal-Weight | Maintains | |
2016-04-05 | BMO Capital | Market Perform | Initiate | |
2016-03-23 | Credit Suisse | Outperform | Maintains | |
2016-03-15 | Jefferies | Hold | Maintains | |
2016-02-25 | Citigroup | Buy | Initiate | |
2016-02-11 | Oppenheimer | Outperform | Initiate | |
2016-02-05 | Leerink Swann | Outperform | Initiate | |
2016-02-03 | Credit Suisse | Outperform | Maintains | |
2016-02-03 | Oppenheimer | Outperform | Maintains | |
2016-02-03 | Standpoint Research | Buy | Initiate | |
2016-01-20 | Credit Suisse | Outperform | Initiate | |
2016-01-15 | Bank of America | Underperform | Neutral | Upgrade |
2015-12-18 | Atlantic Equities | Neutral | Initiate | |
2015-11-05 | PiperJaffray | Neutral | Overweight | Upgrade |
2015-10-20 | Oppenheimer | Outperform | Maintains | |
2015-10-15 | Jefferies | Hold | Maintains | |
2015-10-02 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
2015-09-09 | Jefferies | Hold | Initiate | |
2015-07-29 | Deutsche Bank | Buy | Maintains | |
2015-07-29 | Barclays | Overweight | Maintains | |
2015-07-06 | Bank of America | Underperform | Maintains | |
2015-06-05 | Longbow Research | Buy | Neutral | Downgrade |
2015-03-27 | Raymond James | Strong Buy | Outperform | Downgrade |
2015-02-06 | Credit Suisse | Outperform | Neutral | Downgrade |
2015-02-05 | Citigroup | Buy | Maintains | |
2015-02-04 | UBS | Buy | Maintains | |
2015-01-06 | Barclays | Overweight | Initiate | |
2014-12-23 | Deutsche Bank | Buy | Maintains | |
2014-12-22 | Bank of America | Buy | Underperform | Downgrade |
2014-12-09 | Morgan Stanley | Equal-Weight | Maintains | |
2014-12-05 | JP Morgan | Overweight | Maintains | |
2014-11-10 | Nomura | Buy | Maintains | |
2014-10-31 | Edward Jones | Hold | Initiate | |
2014-10-29 | Nomura | Buy | Maintains | |
2014-10-15 | Raymond James | Outperform | Strong Buy | Upgrade |
2014-10-13 | FBR Capital | Outperform | Maintains | |
2014-09-19 | Citigroup | Buy | Maintains | |
2014-09-10 | Baird | Outperform | Neutral | Downgrade |
2014-08-08 | Raymond James | Outperform | Maintains | |
2014-07-24 | JP Morgan | Overweight | Maintains | |
2014-07-18 | Nomura | Buy | Maintains | |
2014-06-10 | Topeka | Buy | Maintains | |
2014-06-10 | Raymond James | Outperform | Maintains | |
2014-05-09 | Raymond James | Outperform | Maintains | |
2014-04-23 | Nomura | Buy | Maintains | |
2014-04-23 | Deutsche Bank | Buy | Maintains | |
2014-04-22 | Jefferies | Hold | Maintains | |
2014-04-15 | Longbow Research | Buy | Maintains | |
2014-04-14 | Wells Fargo | Buy | Maintains | |
2014-04-10 | Nomura | Buy | Maintains | |
2014-03-27 | Morgan Stanley | Equal-Weight | Initiate | |
2014-02-05 | Stifel Nicolaus | Buy | Maintains | |
2014-02-04 | Nomura | Buy | Maintains | |
2014-02-04 | Baird | Neutral | Outperform | Upgrade |
2014-01-28 | Deutsche Bank | Buy | Maintains | |
2014-01-08 | Nomura | Buy | Initiate | |
2014-01-06 | UBS | Buy | Maintains | |
2013-12-18 | JP Morgan | Overweight | Maintains | |
2013-11-26 | Jefferies | Hold | Maintains | |
2013-11-25 | Deutsche Bank | Buy | Maintains | |
2013-11-20 | Citigroup | Buy | Maintains | |
2013-11-11 | Raymond James | Strong Buy | Outperform | Downgrade |
2013-10-30 | BMO Capital | Outperform | Maintains | |
2013-10-11 | Longbow Research | Neutral | Buy | Upgrade |
2013-07-26 | Atlantic Equities | Neutral | Overweight | Upgrade |
2013-07-26 | Baird | Outperform | Neutral | Downgrade |
2013-06-26 | Sterne Agee | Buy | Maintains | |
2013-06-13 | Argus | Hold | Buy | Upgrade |
2013-06-11 | Sterne Agee | Buy | Maintains | |
2013-05-23 | Topeka | Buy | Initiate | |
2013-05-06 | Baird | Neutral | Outperform | Upgrade |
2013-04-23 | PiperJaffray | Overweight | Maintains | |
2013-04-22 | Morgan Stanley | Overweight | Maintains | |
2013-04-22 | Maxim Group | Buy | Maintains | |
2013-04-16 | Deutsche Bank | Buy | Maintains | |
2013-04-15 | Leerink Swann | Outperform | Maintains | |
2013-04-12 | UBS | Buy | Maintains | |
2013-04-08 | Blaylock Robert Van | Buy | Initiate | |
2013-04-04 | Credit Suisse | Outperform | Maintains | |
2013-03-18 | Citigroup | Buy | Maintains | |
2013-03-14 | Oppenheimer | Outperform | Maintains | |
2013-03-05 | PiperJaffray | Overweight | Maintains | |
2013-02-19 | Credit Suisse | Neutral | Outperform | Upgrade |
2013-02-05 | Atlantic Equities | Overweight | Neutral | Downgrade |
2013-02-05 | Stifel Nicolaus | Buy | Maintains | |
2013-02-05 | UBS | Buy | Maintains | |
2013-02-05 | Jefferies | Hold | Maintains | |
2013-01-30 | Deutsche Bank | Buy | Maintains | |
2013-01-30 | UBS | Buy | Maintains | |
2013-01-03 | Baird | Outperform | Initiate | |
2012-12-27 | Benchmark | Buy | Maintains | |
2012-12-18 | UBS | Buy | Maintains | |
2012-12-18 | Morgan Stanley | Overweight | Maintains | |
2012-12-17 | Sterne Agee | Neutral | Buy | Upgrade |
2012-12-14 | PiperJaffray | Overweight | Maintains | |
2012-12-04 | Barclays | Overweight | Maintains | |
2012-11-13 | Deutsche Bank | Buy | Maintains | |
2012-11-13 | Stifel Nicolaus | Buy | Maintains | |
2012-10-24 | Credit Suisse | Neutral | Maintains | |
2012-10-24 | BMO Capital | Outperform | Maintains | |
2012-10-24 | Jefferies | Hold | Maintains | |
2012-10-15 | Barclays | Overweight | Maintains | |
2012-10-08 | PiperJaffray | Overweight | Maintains | |
2012-10-03 | UBS | Buy | Maintains | |
2012-10-03 | Sterne Agee | Underperform | Maintains | |
2012-10-01 | Bernstein | Market Perform | Outperform | Upgrade |
2012-09-27 | Bank of America | Buy | Maintains | |
2012-09-19 | Deutsche Bank | Buy | Maintains | |
2012-09-17 | JP Morgan | Overweight | Maintains | |
2012-08-30 | UBS | Buy | Maintains | |
2012-08-28 | Jefferies | Hold | Maintains | |
2012-08-28 | Stifel Nicolaus | Buy | Maintains | |
2012-08-15 | Deutsche Bank | Buy | Maintains | |
2012-08-09 | Benchmark | Buy | Maintains | |
2012-08-02 | Barclays | Equal-Weight | Overweight | Upgrade |
2012-08-02 | Deutsche Bank | Buy | Maintains | |
2012-07-27 | Stifel Nicolaus | Buy | Maintains | |
2012-07-27 | Jefferies | Hold | Maintains | |
2012-02-10 | Morgan Stanley | Overweight | Initiate | |
2024-09-04 | RBC Capital | Sector Perform | Sector Perform | Maintains |
2025-02-12 | Piper Sandler | Overweight | Overweight | Maintains |
2025-02-12 | Morgan Stanley | Overweight | Overweight | Maintains |
2025-02-12 | Needham | Hold | Hold | Reiterate |
2025-03-27 | JP Morgan | Overweight | Overweight | Maintains |
2024-09-11 | Piper Sandler | Overweight | Overweight | Maintains |
2024-11-18 | RBC Capital | Sector Perform | Sector Perform | Maintains |
2024-10-04 | RBC Capital | Sector Perform | Sector Perform | Maintains |
2025-03-05 | Wells Fargo | Overweight | Overweight | Maintains |
2025-03-05 | B of A Securities | Buy | Buy | Maintains |
2024-10-09 | JP Morgan | Overweight | Overweight | Maintains |
2025-01-29 | JP Morgan | Overweight | Overweight | Maintains |
2024-12-10 | B of A Securities | Buy | Reiterate | |
2024-12-10 | Oppenheimer | Outperform | Outperform | Maintains |
2025-03-11 | Morgan Stanley | Overweight | Overweight | Maintains |
2025-02-18 | Deutsche Bank | Hold | Buy | Upgrade |
2024-12-11 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
2024-12-11 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
2025-07-25 | Needham | Hold | Buy | Upgrade |
2025-04-25 | Morgan Stanley | Overweight | Overweight | Maintains |
2025-04-25 | Oppenheimer | Outperform | Outperform | Maintains |
2025-04-25 | Needham | Hold | Hold | Reiterate |
2025-08-08 | UBS | Neutral | Neutral | Maintains |
2025-08-08 | RBC Capital | Sector Perform | Sector Perform | Maintains |
2025-08-08 | Truist Securities | Hold | Buy | Upgrade |
2025-05-21 | Needham | Hold | Hold | Reiterate |
Revenue Estimates
No data available.
Earnings Estimates
The forecasted annual earnings of Gilead Sciences, Inc. in 2032-12-31 is 10.10 per share.
One part of an analyst’s rating is a profit (i.e., earnings) estimate for the current quarter and/or future quarters. The measurement given is earnings per share (EPS). EPS is a metric that indicates how much a company earned as represented by one share of its stock over a specific period (typically three months).
To understand the earnings per share calculation, you must understand net income. Net income is the amount of money a company has left over after deducting appropriate expenses and taxes from its revenues).
The formula for earnings per share is net income divided by the total number of outstanding shares (i.e., available for purchase). For example:
Company A has a net income of $100 million and forty million outstanding shares. The EPS calculation is as follows:
100,000,000/40,000,000 = $2.50 per share
Earnings per share is an essential metric for you to consider when deciding to buy a stock. After all, a company with high earnings per share is productive and generates revenue in excess of its operating costs.
However, it’s not the only metric you should use. Metrics like price-to-earnings and debt-to-equity add additional perspective about a company’s health.
You should also be sure to compare a company’s EPS with a company in its sector. However, when you do, be aware that EPS is different and more important than net profit by itself. You may see a company that has a rising net profit. But if its outstanding shares are also rising, then its EPS might be flat or even edging lower.
Update Frequency: Quarterly
Date | EPS Average (Quarterly) | Number of Analysts (Quarterly) | EPS Average (Annual) | Number of Analysts (Annually) |
---|---|---|---|---|
2025-09-30 | 2.07 | 5 | -- | -- |
2025-12-31 | 2.16 | 5 | 7.26 | 32 |
2026-03-31 | 2.10 | 3 | -- | -- |
2026-06-30 | 2.23 | 3 | -- | -- |
2026-09-30 | 2.31 | 3 | -- | -- |
2026-12-31 | 2.25 | 3 | 7.68 | 28 |
2027-12-31 | -- | -- | 8.00 | 17 |
2028-12-31 | -- | -- | 8.44 | 16 |
2029-12-31 | -- | -- | 8.94 | 12 |
2030-12-31 | -- | -- | 9.14 | 11 |
2031-12-31 | -- | -- | 9.67 | 10 |
2032-12-31 | -- | -- | 10.10 | 8 |